Trial Profile
A phase I/IIa trial of T-cell therapy in acute myeloid leukaemia
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs TEG-001 (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 04 Apr 2016 New trial record